Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

460 results about "Neuro surgery" patented technology

Neurosurgery, or neurological surgery, is the medical specialty concerned with the prevention, diagnosis, surgical treatment, and rehabilitation of disorders which affect any portion of the nervous system including the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system.

Automatic visual location device and automatic visual location method for head marks of patient in stereotactic neurosurgery

The invention discloses an automatic visual location device and an automatic visual location method for head marks of a patient in stereotactic neurosurgery. The method comprises the following steps of: designing a mark template; pasting marks on the head of the patient by using a specific method; acquiring pixel coordinates of mark centers of single-frame left and right eye images in video by using an image processing and pattern recognition method, and reconstructing the pixel coordinates into spatial coordinates by using a computer vision method; and tracking to acquire pixel coordinates of a mark center of a video sequence by using the image processing and pattern recognition method, and reconstructing the pixel coordinates into spatial coordinates by using the computer vision method.In the invention, the traditional method of manually selecting mark centers in the neurosurgery is changed, the automation of the location of the mark centers is realized, operation steps are simplified, and operation time is shortened; location results are more accurate; and the reliability of the operation is improved. The automatic visual location device and the automatic visual location method can be promoted and applied, and solve the problem of the location and tracking of the mark centers in surgeries such as bone surgeries and the like.
Owner:BEIJING BAIHUI WEIKANG SCI & TECH CO LTD

Methods

The present invention relates to the use of selective aquaporin inhibitors, e.g., of aquaporin-4 or aquaporin-2, e.g., certain phenylbenzamide compounds, for the prophylaxis, treatment and control of aquaporin-mediated conditions, e.g., diseases of water imbalance, for example edema (particularly edema of the brain and spinal cord, e.g., following trauma or ischemic stroke, as well as the edema associated with glioma, meningitis, acute mountain sickness, epileptic seizures, infections, metabolic disorders, hypoxia, water intoxication, hepatic failure, hepatic encephalopathy, diabetic ketoacidosis, abscess, eclampsia, Creutzfeldt-Jakob disease, and lupus cerebritis, as well as edema consequent to microgravity and/or radiation exposure, as well as edema consequent to invasive central nervous system procedures, e.g., neurosurgery, endovascular clot removal, spinal tap, aneurysm repair, or deep brain stimulation, as well as retinal edema), as well as hyponatremia and excess fluid retention, and diseases such as epilepsy, retinal ischemia and other diseases of the eye associated with abnormalities in intraocular pressure and/or tissue hydration, myocardial ischemia, myocardial ischemia/reperfusion injury, myocardial infarction, myocardial hypoxia, congestive heart failure, sepsis, and neuromyelitis optica, as well as migraines, as well as to novel assays for identifying aquaporin inhibitors.
Owner:AEROMICS

Preparation process of dalteparin sodium

The invention discloses a preparation process of dalteparin sodium. The preparation process comprises the following steps: preparing a heparin sodium solution, a heparin degradation fluid, a reducing solution and a crude product, refining, freeze-drying and the like. The average molecular weight of the obtained product is 5,500 to 6,500, the peak molecular weight is 3,500 to 6,000, a component with the molecular weight of less than 3,000 is not greater than 13% , a component with the molecular weight of greater than 8,000 is not greater than 15%, anti-Xa activity is more than or equal to 130IU/mg. The invention has the advantages of rich source of raw materials, high yield, stable and reliable quality, high purity, low cost, simple process, easiness in operation and no waste discharge. The dalteparin sodium has the anticoagulant, antithrombotic, anti-tumor, anti-inflammatory, anti-allergy and blood lipid regulating effects, thereby having a significant curative effect. The dalteparin sodium can be used for preventing preoperative and postoperative thrombosis of general surgery, orthopedic surgery and neurosurgery, effectively preventing venous thromboembolism of ischemic stroke patients, greatly reducing the risk of stroke, effectively preventing the solidification caused by extracorporeal circulation of blood, effectively preventing the instable coronary heart disease, and having a wide usable range.
Owner:HEBEI CHANGSHAN BIOCHEM PHARMA

Method for preparing enoxaparin sodium

The invention discloses a method for preparing enoxaparin sodium, comprising the steps of salinizing, drying, esterfying, alcohol precipitating, oxidizing, alcohol precipitating, fine filtering and freeze drying. In the method provided by the invention, a hydrophilic liquid phase reaction, a hydrophobic liquid phase reaction and a solid phase reaction are adopted, so that macromolecule sodium heparin is degraded into micromolecule sodium heparin with a specific structure, and the molecular weights of products and molecular weight distribution ranges are controlled, thus anti-FIIa activity resulting in bleeding risk is greatly reduced, the anti-FXa activity is relatively improved, and the product effectiveness and safety advantages are obvious. The enoxaparin sodium can be used for effectively preventing venous thromboembolism and pulmonary embolism, can be used for thrombosis before and after operations of orthopedic surgery and neurosurgery, and can be used for greatly reducing apoplexy risk, more effectively reducing death, cardiac failure and recurrent angina of patients suffering from unstable coronary artery syndromes, reducing hypertriglyceridemia and effectively eliminating the side effects of haemorrhage, osteoporosis and induced thrombocytopenia after long-term use of common unfractionated heparin sodium and derivates of common unfractionated heparin sodium.
Owner:HEBEI CHANGSHAN BIOCHEM PHARMA

Neurosurgery clinical nursing head fixing device

The invention discloses a neurosurgery clinical nursing head fixing device. The device comprises a chassis, a gearbox is arranged in the chassis, an adjusting threaded rod is arranged on the upper endof the gearbox, a threaded sleeve is arranged on the upper end of the adjusting threaded rod, the upper end of the threaded sleeve is connected with a hinged frame, the hinged frame is connected to the lower end surface of a pillow seat, limit sliding grooves are formed in the left and right sides of the inside of the pillow seat, the limit sliding grooves are provided with a rotating threaded rod and a threaded sliding block, the upper end of the threaded sliding block is provided with a connecting block, the upper end of the connecting block is provided with a fixing plate, the fixing plateis a curved plate, and the inner side surface of the fixing plate is provided with a sponge pad. The device is stable in structure, stable in operation, convenient to adjust, convenient to use and quick in loading and unloading, is capable of achieving a head fixing function for clinical nursing of neurosurgery, can be applied to the head fixing of different patients, has wide applicability, canachieve the lifting adjustment function, can achieve the rotation function, provides convenience for the operation of a surgery and the nursing function, and satisfies the current use requirements.
Owner:孙永霞

Multi-purpose clinical treatment device for neurosurgery department

The invention discloses a multi-purpose clinical treatment device for the neurosurgery department. The multi-purpose clinical treatment device comprises a bed board, wherein the front end of the bed board is in sliding connection with an opening end of a U-shaped slider, two positioning suckers are adsorbed to the upper surface of the bed board, a fastening bolt is arranged on the front side face of the slider corresponding to the bed board, a single chip microcomputer is fixed to the right end of the front side face of the slider, a first stepping motor is fixed on the upper surface of the slider, an output shaft of the first stepping motor is fixedly connected with the lower end of a second electric telescopic rod through a coupler, when a patient moves unconsciously, the position of a wound moves, the single-chip microcomputer controls a first electric telescopic rod, the second electric telescopic rod, the first stepping motor, a third electric telescopic rod and a second stepping motor to work, so that a baking lamp always irradiates a wound, and the treatment effect is good; the single-chip microcomputer detects the distance between the positioning suckers and the baking lamp through a visual sensor, then the detection for the position of the wound is converted into the detection for the positions of the positioning suckers, and the positioning is simple and accurate.
Owner:郭林平
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products